Preparation of oridonin-loaded solid lipid nanoparticles and studies on them in vitro and in vivo

Nanotechnology

Volumn 17, Issue 23, 2006, Pages 5821-5828

  Zhang, Dianrui ^a,b   Tan, Tianwei ^a   Gao, Lei ^b  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; ELECTROPHORESIS; EMULSIONS; EVAPORATION; LIPIDS; NANOSTRUCTURED MATERIALS; SOLIDIFICATION; SOLUBILITY; TRANSMISSION ELECTRON MICROSCOPY;

LIPOPHILIC CHINESE MEDICINE; SOLID LIPID NANOPARTICLE (SLN) DELIVERY SYSTEMS; SOLID LIPID NANOPARTICLES; SOYBEAN LECITHIN;

PROTEINS;

EID: 33846062405     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/17/23/018     Document Type: Article

References (27)

1. Zhang D R and Ren T C 2003 Pharmaceutical progress of Oridonin Chin. Pharm. J. 38 817-20
2. Fujita T, Takeda Y, Sun H D, Minami Y, Marunaka T and Takeda S 1988 Cytotoxic and antitumor activities of Rabdosia diterpenoids Planta. Med. 54 414-7
3. Osawa K, Yasuda H, Maruyama T, Morita H, Takeya K and Itokawa H 1994 Antibacterial trichorabdal diterpenes from Rabdosia trichocarpa Phytochemistry 36 1287-91
4. Zhang Y, Wang J, Lou L G, Zhang T M, Hou J W and Xin W J 1999 Scavenging effect of oridonin on active oxygen free radicals, Henan Med. Res. 8 100-4
5. Han Q B, Li M L, Li S H, Mou Y K, Lin Z W and Sun H D 2003 Ent-kaurane diterpenoids from Isodon rubescens var.lushanensis Chem. Pharm. Bull. 51 790-3
6. Ge M, Ma Y F, Zhang Z X, Ma A M and Liu H G 1981 Lethal effects of oridonin and ponicidin on human cell line BEL-7402 Chin. Pharm. J. 16 6-9
7. Ikezoe T, Chen S S, Tong X J, Heber D, Taguchi H and Koeffler H P 2003 Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells Int. J. Oncol. 23 1187-93
8. Chen S, Gao J, Halicka H D, Huang X, Traganos F and Darzynkiewicz Z 2005 The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage Int. J. Oncol. 26 579-88
9. Muller R H, Mader K and Gohla S 2000 Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur. J. Pharm. Biopharm. 50 161-77
10. Muller R H and Keck C M 2004 Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles J. Biotech. 113 151-70
11. Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C and Mader K 2004 Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy J. Control. Release 95 217-27
12. Tabatt K, Keneuer C, Sameti M, Olbrich C, Muller R H, Lehr C M and Bakowsky U 2004 Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes J. Control. Release 97 321-32
13. Kim B D, Na K and Choi H K 2005 Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan Eur. J. Pharm. Sci. 24 199-205
14. Cavalli R, Gasco M R, Chetoni P, Burgalassi S and Saettone M F 2002 Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin Int. J. Pharm. 238 241-5
15. Mehnert W and Mader K 2001 Solid lipid nanoparticles: production, characterization and applications Adv. Drug. Deliv. Rev. 47 165-9
16. Yang S, Zhu J, Lu Y, Liang B and Yang C 1999 Body distribution of camptothecin solid lipid nanoparticles after oral administration Pharm. Res. 16 751-7
17. Schubert M A, Harms M and Muller-Goymann C C 2006 Structural investigations on lipid nanoparticles containing high amounts of lecithin Eur. J. Pharm. Sci. 27 226-36
18. Manjunath K, Reddy J S and Venkateswarlu V 2005 Solid lipid nanoparticles as drug delivery systems Methods Find Exp. Clin. Pharmacol. 27 127-44
19. Siekmann B and Westesen K 1994 Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. I. Preparation and particle size determination Pharm. Pharmacol. Lett. 3 194-201
20. Cavalli R, Aquilano D, Carlotti M E and Gasco M R 1995 Study by x-ray powder diffraction and differential scanning calorimetry of two model drugs, phenothiazine and nifedipine, incorporated into lipid nanoparticles Eur. J. Pharm. Biopharm. 41 329-33
21. Cavalli R, Caputo O, Carlotti M E, Trotta M, Scarnecchia C and Gasco M R 1997 Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles Int. J. Pharm. 148 47-54
22. Vobalaboina V and Kopparam M 2004 Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles J. Control. Release 95 627-38
23. Corrigan O I, Holohan E M and Reilly H R 1985 Physical-chemical properties of indomethacin and related compounds co-spraydried with polyvinyl pyrrolidone Drug Dev. Ind. Pharm. 11 677-89
24. Corrigan D O, Healy A M and Corrigan O I 2003 The effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materials Int. J. Pharm. 262 125-37
25. Hancock B C, Carlson G T and Ladipo D D 2002 Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance Int. J. Pharm. 241 73-85
26. Lifeng Q and Zirong X 2006 In vivo antitumor activity of chitosan nanoparticles Bioorg. Med. Chem. Lett. 16 4243-5
27. Li Y, Dong L, Jia A, Chang X and Xue H 2006 Preparation and characterization of solid lipid nanoparticles loaded traditional chinese medicine Int. J. Biol. Macromol. 38 296-9